Your browser doesn't support javascript.
loading
Golgi Phosphoprotein 3 Confers Radioresistance via Stabilizing EGFR in Lung Adenocarcinoma.
Chen, Guodong; Kong, Peizhong; Yang, Miaomiao; Hu, Wanglai; Prise, Kevin M; Yu, K N; Cui, Shujun; Qin, Feng; Meng, Gang; Almahi, Waleed Abdelbagi; Nie, Lili; Han, Wei.
Afiliação
  • Chen G; Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, PR China; Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, PR China.
  • Kong P; Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, PR China; Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, PR China.
  • Yang M; Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, PR China; University of Science and Technology of China, Hefei, PR China; Clinical Pathology Center, The Fourth Affil
  • Hu W; School of Basic Medical Science, Anhui Medical University, Hefei, PR China.
  • Prise KM; Centre for Cancer Research & Cell Biology, Queen's University Belfast, Belfast, United Kingdom.
  • Yu KN; Department of Physics, City University of Hong Kong, Hong Kong, PR China; State Key Laboratory in Marine Pollution, City University of Hong Kong, Hong Kong, PR China.
  • Cui S; Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, PR China; University of Science and Technology of China, Hefei, PR China.
  • Qin F; Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, PR China; University of Science and Technology of China, Hefei, PR China.
  • Meng G; Clinical Pathology Center, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, PR China; Department of Pathology, Anhui Medical University, Hefei, PR China.
  • Almahi WA; Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, PR China; University of Science and Technology of China, Hefei, PR China.
  • Nie L; Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, PR China; Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, PR China.
  • Han W; Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, PR China; Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, PR China; Collaborative Innovation Center of Rad
Int J Radiat Oncol Biol Phys ; 112(5): 1216-1228, 2022 04 01.
Article em En | MEDLINE | ID: mdl-34838866
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article